These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 30963251)

  • 41. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.
    Hüffmeier U; Zenker M; Hoyer J; Fahsold R; Rauch A
    Am J Med Genet A; 2006 Dec; 140(24):2749-56. PubMed ID: 17103458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant G protein signaling in nervous system tumors.
    Woods SA; Marmor E; Feldkamp M; Lau N; Apicelli AJ; Boss G; Gutmann DH; Guha A
    J Neurosurg; 2002 Sep; 97(3):627-42. PubMed ID: 12296648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gliomas in patients with neurofibromatosis type 1.
    Albers AC; Gutmann DH
    Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurofibromatosis type 1: pathology, clinical features and molecular genetics.
    von Deimling A; Krone W; Menon AG
    Brain Pathol; 1995 Apr; 5(2):153-62. PubMed ID: 7670656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome?
    Fareez F; Wang BH; Brain I; Lu JQ
    Pathology; 2023 Apr; 55(3):302-314. PubMed ID: 36774237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway.
    Feldkamp MM; Angelov L; Guha A
    Surg Neurol; 1999 Feb; 51(2):211-8. PubMed ID: 10029430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
    Su W; Xing R; Guha A; Gutmann DH; Sherman LS
    Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurofibromatosis type 1.
    North K
    Am J Med Genet; 2000; 97(2):119-27. PubMed ID: 11180219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.
    Peces R; Mena R; Martín Y; Hernández C; Peces C; Tellería D; Cuesta E; Selgas R; Lapunzina P; Nevado J
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1321. PubMed ID: 32533764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association.
    Brems H; Park C; Maertens O; Pemov A; Messiaen L; Upadhyaya M; Claes K; Beert E; Peeters K; Mautner V; Sloan JL; Yao L; Lee CC; Sciot R; De Smet L; Legius E; Stewart DR
    Cancer Res; 2009 Sep; 69(18):7393-401. PubMed ID: 19738042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.
    Gutmann DH; Donahoe J; Brown T; James CD; Perry A
    Neuropathol Appl Neurobiol; 2000 Aug; 26(4):361-7. PubMed ID: 10931370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
    Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
    Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emerging therapeutic targets for neurofibromatosis type 1.
    Walker JA; Upadhyaya M
    Expert Opin Ther Targets; 2018 May; 22(5):419-437. PubMed ID: 29667529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.
    Lasater EA; Bessler WK; Mead LE; Horn WE; Clapp DW; Conway SJ; Ingram DA; Li F
    Hum Mol Genet; 2008 Aug; 17(15):2336-44. PubMed ID: 18442999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.
    Bouley SJ; Grassetti AV; Allaway RJ; Wood MD; Hou HW; Burdon Dasbach IR; Seibel W; Wu J; Gerber SA; Dragnev KH; Walker JA; Sanchez Y
    J Cell Sci; 2024 Aug; 137(15):. PubMed ID: 39016685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.
    Kluwe L; Hagel C; Tatagiba M; Thomas S; Stavrou D; Ostertag H; von Deimling A; Mautner VF
    J Neuropathol Exp Neurol; 2001 Sep; 60(9):917-20. PubMed ID: 11556548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
    Romo CG; Piotrowski AF; Campian JL; Diarte J; Rodriguez FJ; Bale TA; Dahiya S; Gutmann DH; Lucas CG; Prichett L; Mellinghoff I; Blakeley JO
    Neuro Oncol; 2023 Aug; 25(8):1474-1486. PubMed ID: 36840626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.